These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 25939298)
1. Statins and the liver. Herrick C; Bahrainy S; Gill EA Cardiol Clin; 2015 May; 33(2):257-65. PubMed ID: 25939298 [TBL] [Abstract][Full Text] [Related]
2. Statins and the Liver. Herrick C; Bahrainy S; Gill EA Endocrinol Metab Clin North Am; 2016 Mar; 45(1):117-28. PubMed ID: 26893001 [TBL] [Abstract][Full Text] [Related]
3. Lipid lowering in liver and chronic kidney disease. Herrick C; Litvin M; Goldberg AC Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):339-52. PubMed ID: 24840263 [TBL] [Abstract][Full Text] [Related]
4. The potential role of statins in treating liver disease. Imprialos KP; Stavropoulos K; Doumas M; Skalkou A; Zografou I; Athyros VG Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):331-339. PubMed ID: 29431526 [TBL] [Abstract][Full Text] [Related]
5. A review of perioperative statin therapy for noncardiac surgery. Skrlin S; Hou V Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):283-90. PubMed ID: 21041202 [TBL] [Abstract][Full Text] [Related]
6. Use of statins in patients with chronic hepatitis C. Andrus MR; East J South Med J; 2010 Oct; 103(10):1018-22; quiz 1023. PubMed ID: 20818300 [TBL] [Abstract][Full Text] [Related]
7. [Impact of lipid lowering therapy on liver function]. Paragh G; Fülöp P Orv Hetil; 2009 Jun; 150(26):1205-12. PubMed ID: 19546077 [TBL] [Abstract][Full Text] [Related]
8. 3-Hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes. Blum A; Simsolo C; Hasin Y Atherosclerosis; 2004 Jul; 175(1):1-5. PubMed ID: 15186940 [No Abstract] [Full Text] [Related]
9. Lipid lowering therapy in atherosclerosis. Aikawa M; Libby P Semin Vasc Med; 2004 Nov; 4(4):357-66. PubMed ID: 15861316 [TBL] [Abstract][Full Text] [Related]
11. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering. Pedersen TR Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729 [TBL] [Abstract][Full Text] [Related]
12. Modulation of heat shock proteins by statins. Forouzanfar F; Butler AE; Banach M; Barreto GE; Sahbekar A Pharmacol Res; 2018 Aug; 134():134-144. PubMed ID: 29935271 [TBL] [Abstract][Full Text] [Related]
13. Statins, cardiovascular disease, and drug safety. Gotto AM Am J Cardiol; 2006 Apr; 97(8A):3C-5C. PubMed ID: 16581326 [TBL] [Abstract][Full Text] [Related]
14. Statins and cardiovascular risk in rheumatic diseases. Marasini B; Massarotti M Int J Immunopathol Pharmacol; 2012; 25(1):25-30. PubMed ID: 22507314 [TBL] [Abstract][Full Text] [Related]
15. The Safety and Benefit of Statins in Liver Cirrhosis: a Review. Souk K; Al-Badri M; Azar ST Exp Clin Endocrinol Diabetes; 2015 Nov; 123(10):577-80. PubMed ID: 26600051 [TBL] [Abstract][Full Text] [Related]
16. Defining patient risks from expanded preventive therapies. Tolman KG Am J Cardiol; 2000 Jun; 85(12A):15E-9E. PubMed ID: 10858489 [TBL] [Abstract][Full Text] [Related]
17. Statins' role in prevention. Do statins have a role in primary prevention of cardiovascular events? Can Fam Physician; 2004 Aug; 50():1091. PubMed ID: 15455806 [No Abstract] [Full Text] [Related]
18. Dyslipidemia: management using optimal lipid-lowering therapy. Ito MK Ann Pharmacother; 2012 Oct; 46(10):1368-81. PubMed ID: 23032652 [TBL] [Abstract][Full Text] [Related]